NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis $14.38 -0.24 (-1.64%) Closing price 03:59 PM EasternExtended Trading$14.38 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Vicarious Surgical Stock (NYSE:RBOT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vicarious Surgical alerts:Sign Up Key Stats Today's Range$13.60▼$14.6350-Day Range$11.84▼$16.0252-Week Range$4.27▼$19.00Volume73,712 shsAverage Volume53,533 shsMarket Capitalization$84.96 millionP/E RatioN/ADividend YieldN/APrice Target$10.25Consensus RatingHold Company OverviewVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More… Vicarious Surgical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreRBOT MarketRank™: Vicarious Surgical scored higher than 28% of companies evaluated by MarketBeat, and ranked 809th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageVicarious Surgical has received no research coverage in the past 90 days.Read more about Vicarious Surgical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vicarious Surgical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.43% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently increased by 29.07%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.43% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently increased by 29.07%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment0.55 News SentimentVicarious Surgical has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest1 people have searched for RBOT on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,399.00 in company stock.Percentage Held by Insiders11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Vicarious Surgical's insider trading history. Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address RBOT Stock News HeadlinesVicarious Surgical announces planned retirement of COO MazzolaFebruary 18 at 6:22 PM | markets.businessinsider.comVicarious Surgical Announces Planned Retirement of Chief Operating OfficerFebruary 18 at 4:31 PM | businesswire.comYour trading day could end at 11 AMWhat do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?February 21, 2025 | ProsperityPub (Ad)Vicarious Surgical enters consulting agreement with former CFOJanuary 21, 2025 | msn.comVicarious Surgical Secures Advisory Role with Former CFOJanuary 21, 2025 | tipranks.comIn a first, surgical robots learned tasks by watching videosDecember 31, 2024 | msn.comPetri Dish: EMD Serono’s new president; Prostate cancer drug successDecember 12, 2024 | bizjournals.comBTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)December 8, 2024 | markets.businessinsider.comSee More Headlines RBOT Stock Analysis - Frequently Asked Questions How have RBOT shares performed this year? Vicarious Surgical's stock was trading at $13.16 at the beginning of 2025. Since then, RBOT shares have increased by 9.3% and is now trading at $14.38. View the best growth stocks for 2025 here. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) issued its quarterly earnings data on Monday, March, 4th. The company reported ($2.10) earnings per share for the quarter, topping analysts' consensus estimates of ($3.60) by $1.50. When did Vicarious Surgical's stock split? Vicarious Surgical shares reverse split before market open on Thursday, June 13th 2024. The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Who are Vicarious Surgical's major shareholders? Top institutional investors of Vicarious Surgical include DDD Partners LLC (3.14%), Geode Capital Management LLC (0.52%), DnB Asset Management AS (0.36%) and Renaissance Technologies LLC (0.20%). Insiders that own company stock include Ventures V LP Khosla, Adam David Sachs, Sammy Khalifa, June Morris, William John Kelly, John Mazzola and Philip Liang. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vicarious Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI). Company Calendar Last Earnings3/04/2024Today2/21/2025Next Earnings (Estimated)4/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Target$10.25 High Stock Price Target$10.50 Low Stock Price Target$10.00 Potential Upside/Downside-27.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($10.2948) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-71,070,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-81.46% Return on Assets-63.62% Debt Debt-to-Equity RatioN/A Current Ratio7.44 Quick Ratio7.44 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$16.76 per share Price / Book0.85Miscellaneous Outstanding Shares5,910,000Free Float5,215,000Market Cap$83.80 million OptionableOptionable Beta1.32 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NYSE:RBOT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free rbot Stock Alerts